Bright Green Plans $300M Cannabis Facility In New Mexico
The project is expected to create more than 170 construction jobs and an initial 200 research and agricultural jobs.
Based in Grants, Bright Green (BGC) was approved by the Drug Enforcement Administration to facilitate the production, storage, packaging, and distribution of medical research marijuana under the new regulations, as well as other applicable legal standards and relevant laws. BGC executed a memorandum of agreement with the DEA earlier this week.
To obtain authorization from the DEA, applicants are responsible for demonstrating they have met various requirements, including requirements to possess appropriate state authority, document that their customers are licensed to perform research, and employ adequate safeguards to prevent diversion.
“Legal compliance is at the crux of our company ethos, and we will comply with all federal, state, and local laws to supply cannabis for federally sanctioned research. Bright Green will deliver consistent, pure, high-quality organic cannabis and cannabis extracts that will provide safe inventory for cannabis researchers around the nation,” said Robinson. “This accomplishment could not have been achieved without the demonstrated commitment of the DEA and the State of New Mexico.”
Learn more at brightgreen.us.